What does APOTHEEK FARMAPUNT MORTSEL do?

APOTHEEK FARMAPUNT MORTSEL is a pharmacy in Mortsel. Private Limited, started on 27 January 2015, 1 establishment.

What is the address of APOTHEEK FARMAPUNT MORTSEL?

The registered office of APOTHEEK FARMAPUNT MORTSEL is located at Deurnestraat 143, 2640 Mortsel.

Is APOTHEEK FARMAPUNT MORTSEL still active?

Yes. According to the CBE (16 September 2026) APOTHEEK FARMAPUNT MORTSEL is active, legal situation “Normale toestand”, started on 27 January 2015.

Is APOTHEEK FARMAPUNT MORTSEL registered on Peppol?

Yes, APOTHEEK FARMAPUNT MORTSEL is registered on the Peppol network with ID 0208:0578945587.

What is the enterprise number of APOTHEEK FARMAPUNT MORTSEL?

The enterprise number of APOTHEEK FARMAPUNT MORTSEL is BE0578945587.

When was APOTHEEK FARMAPUNT MORTSEL founded?

APOTHEEK FARMAPUNT MORTSEL was founded on 27 January 2015.

Who are the directors of APOTHEEK FARMAPUNT MORTSEL?

According to the 2025 annual accounts, the directors of APOTHEEK FARMAPUNT MORTSEL are: Karlien Onclin.

Is APOTHEEK FARMAPUNT MORTSEL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 January 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK FARMAPUNT MORTSEL make in 2025?

APOTHEEK FARMAPUNT MORTSEL posted a profit after taxes of € 153,974 in financial year 2025.

What is the revenue of APOTHEEK FARMAPUNT MORTSEL?

As a small company, APOTHEEK FARMAPUNT MORTSEL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 605,610.

How much does an employee at APOTHEEK FARMAPUNT MORTSEL earn?

The average wage cost per full-time employee at APOTHEEK FARMAPUNT MORTSEL was € 58,500 in 2025: staff costs of € 204,869 for 3.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK FARMAPUNT MORTSEL have?

According to the 2025 annual accounts, APOTHEEK FARMAPUNT MORTSEL has 3.5 full-time equivalents (FTE).

APOTHEEK FARMAPUNT MORTSEL (Private Limited) - Mortsel

Dossier APOTHEEK FARMAPUNT MORTSEL, printed on 16 September 2026 from databakkes.be/en/0578945587/apotheek-farmapunt-mortsel. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK FARMAPUNT MORTSEL from Mortsel, company number BE0578945587, closed financial year 2025 with a result of € 153,974 after tax. For that financial year APOTHEEK FARMAPUNT MORTSEL recorded a gross margin of € 605,610 and equity of € 25,996. Compared with financial year 2024, the result moved from € 101,456 to € 153,974. Profitable, and profit is growing. The buffer shrank hard: equity is 84 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 5, 2026.

What it is worth Shrank hard

€ 25,996

▼ 84% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 153,974

▲ 52% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 379,063

▲ 63% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 290,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

3.5

▲ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 204,869

▲ 3% vs 2024

€ 58,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 17,189

▼ 33% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 412,797

▼ 12% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 72,734

▼ 15% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 48,280

▲ 39% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 398,797 Gross margin 2022: € 398,797 First fiscal year in the series	€ 429,730 Gross margin 2023: € 429,730 ▲ 8% vs 2022 (€ 398,797) Favourable step	€ 536,182 Gross margin 2024: € 536,182 ▲ 25% vs 2023 (€ 429,730) Favourable step	€ 605,610 Gross margin 2025: € 605,610 ▲ 13% vs 2024 (€ 536,182) Favourable step	▲ 13%
Profit after taxes	€ 64,689 Profit after taxes 2022: € 64,689 First fiscal year in the series	€ 53,920 Profit after taxes 2023: € 53,920 ▼ 17% vs 2022 (€ 64,689) Unfavourable step	€ 101,456 Profit after taxes 2024: € 101,456 ▲ 88% vs 2023 (€ 53,920) Favourable step	€ 153,974 Profit after taxes 2025: € 153,974 ▲ 52% vs 2024 (€ 101,456) Favourable step	▲ 52%
Equity	€ 306,646 Equity 2022: € 306,646 First fiscal year in the series	€ 60,565 Equity 2023: € 60,565 ▼ 80% vs 2022 (€ 306,646) Unfavourable step	€ 162,022 Equity 2024: € 162,022 ▲ 168% vs 2023 (€ 60,565) Favourable step	€ 25,996 Equity 2025: € 25,996 ▼ 84% vs 2024 (€ 162,022) Unfavourable step	▼ 84%
Total debts	€ 851,065 Total debts 2022: € 851,065 First fiscal year in the series	€ 1,029,748 Total debts 2023: € 1,029,748 ▲ 21% vs 2022 (€ 851,065) Unfavourable step	€ 924,878 Total debts 2024: € 924,878 ▼ 10% vs 2023 (€ 1,029,748) Favourable step	€ 1,133,656 Total debts 2025: € 1,133,656 ▲ 23% vs 2024 (€ 924,878) Unfavourable step	▲ 23%
Cash	€ 245,087 Cash 2022: € 245,087 First fiscal year in the series	€ 252,183 Cash 2023: € 252,183 ▲ 3% vs 2022 (€ 245,087) Favourable step	€ 231,945 Cash 2024: € 231,945 ▼ 8% vs 2023 (€ 252,183) Unfavourable step	€ 379,063 Cash 2025: € 379,063 ▲ 63% vs 2024 (€ 231,945) Favourable step	▲ 63%
Land & buildings	€ 331,936 Land & buildings 2022: € 331,936 First fiscal year in the series	€ 316,848 Land & buildings 2023: € 316,848 ▼ 5% vs 2022 (€ 331,936) Unchanged	€ 301,760 Land & buildings 2024: € 301,760 ▼ 5% vs 2023 (€ 316,848) Unchanged	€ 286,672 Land & buildings 2025: € 286,672 ▼ 5% vs 2024 (€ 301,760) Unchanged	▼ 5%
Retained profit	€ 288,046 Retained profit 2022: € 288,046 First fiscal year in the series	€ 41,965 Retained profit 2023: € 41,965 ▼ 85% vs 2022 (€ 288,046) Unfavourable step	€ 143,422 Retained profit 2024: € 143,422 ▲ 242% vs 2023 (€ 41,965) Favourable step	€ 7,396 Retained profit 2025: € 7,396 ▼ 95% vs 2024 (€ 143,422) Unfavourable step	▼ 95%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 300,000 Dividend 2023: € 300,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 300,000) Unchanged	€ 290,000 Dividend 2025: € 290,000 Unchanged (€ 0) Unchanged
Bank debt	€ 680,994 Bank debt 2022: € 680,994 First fiscal year in the series	€ 576,806 Bank debt 2023: € 576,806 ▼ 15% vs 2022 (€ 680,994) Favourable step	€ 471,658 Bank debt 2024: € 471,658 ▼ 18% vs 2023 (€ 576,806) Favourable step	€ 412,797 Bank debt 2025: € 412,797 ▼ 12% vs 2024 (€ 471,658) Favourable step	▼ 12%
Balance sheet total	€ 1,157,711 Balance sheet total 2022: € 1,157,711 First fiscal year in the series	€ 1,090,314 Balance sheet total 2023: € 1,090,314 ▼ 6% vs 2022 (€ 1,157,711) Unchanged	€ 1,086,899 Balance sheet total 2024: € 1,086,899 Unchanged (€ 1,090,314) Unchanged	€ 1,159,652 Balance sheet total 2025: € 1,159,652 ▲ 7% vs 2024 (€ 1,086,899) Unchanged	▲ 7%
Employees (FTE)	1.5 Employees (FTE) 2022: 1.5 First fiscal year in the series	0 Employees (FTE) 2023: 0 ▼ 1.5 vs 2022 (1.5) Unchanged	3.1 Employees (FTE) 2024: 3.1 Unchanged (0) Unchanged	3.5 Employees (FTE) 2025: 3.5 ▲ 0.4 vs 2024 (3.1) Unchanged	▲ 0.4

Key figures of APOTHEEK FARMAPUNT MORTSEL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK FARMAPUNT MORTSEL?

What happened at APOTHEEK FARMAPUNT MORTSEL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 5, 2026 New annual accounts for financial year 2025: profit of € 153,974 (▲ 52% vs 2024). filed late Source: NBB ↗
Jan 27, 2015 New establishment in Mortsel. KBO
2015 Karlien Onclin became a director. NBB
Jan 27, 2015 Start of the company according to the CBE. KBO

In short

From € 64,689 profit in 2022 to € 153,974 profit in 2025.

Paid € 111,044 in corporate taxes since 2022.

Best year ever: 2025, with € 153,974 profit.

On average € 173,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at APOTHEEK FARMAPUNT MORTSEL? We notify you, reason included.

Follow APOTHEEK FARMAPUNT MORTSEL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Karlien Onclin

APOTHEEK FARMAPUNT MORTSEL

HEDRAS

Behind APOTHEEK FARMAPUNT MORTSEL is Karlien Onclin. Karlien Onclin is also behind HEDRAS.

See the full network in the app

Directors

According to the 2025 annual accounts

Karlien Onclin

Director

Also active at: HEDRAS

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Deurnestraat 143

2640 Mortsel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0578.945.587
VAT number: BE 0578.945.587
Registered office: Deurnestraat 143, 2640 Mortsel
Names & denominations: APOTHEEK FARMAPUNT MORTSEL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 January 2015
Peppol: Active · Active since 24 Nov 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗